In the process of cytotoxic lymphocyte killing target cells, cytotoxic lymphocyte-derived GZMA cleaves pore activity, thereby triggering target cell pyroptosis, a molecular mechanism that enhances anti-tumor immunity [49]. The gene discussed is GZMA; the disease is neoplasm.